Accurate assessment of blood haemostasis is essential for the management of patients who use extracorporeal devices, receive anticoagulation therapy or experience coagulopathies. However, current ...
Investigational once-weekly efanesoctocog alfa prophylaxis met the primary efficacy endpoint providing clinically meaningful bleed protection for people with severe haemophilia A Results underscore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback